Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharmeen Roy

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Open Forum Infectious Diseases|March 12, 2025
Big Data Bayesian Truths: No Vancomycin Trough Concentration Target Is Sufficiently Precise for Safety or EfficacyJustin Shiau, Sharmeen Roy, Paul Sabourenkov, et al.
Molecular Genetics & Genomic Medicine|August 8, 2019
Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida populationDaria Salyakina, Sharmeen Roy, Weize Wang, et al.
Therapeutic Drug Monitoring|April 10, 2025
A Bayesian Framework for Optimizing Amikacin Therapy in Critically Ill Patients With CancerPriscila Akemi Yamamoto, Leyanis Rodriguez-Vera, João Paulo Telles, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Open Forum Infectious Diseases|March 12, 2025
Big Data Bayesian Truths: No Vancomycin Trough Concentration Target Is Sufficiently Precise for Safety or EfficacyJustin Shiau, Sharmeen Roy, Paul Sabourenkov, et al.
Molecular Genetics & Genomic Medicine|August 8, 2019
Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida populationDaria Salyakina, Sharmeen Roy, Weize Wang, et al.
Therapeutic Drug Monitoring|April 10, 2025
A Bayesian Framework for Optimizing Amikacin Therapy in Critically Ill Patients With CancerPriscila Akemi Yamamoto, Leyanis Rodriguez-Vera, João Paulo Telles, et al.
Pageof 1